Tourmaline Bio Inc

NEW
NAS:TRML (USA)  
$ 25.52 -0.96 (-3.63%) 07:09 PM EST
At Loss
P/B:
2.01
Market Cap:
$ 654.37M
Enterprise V:
$ 390.81M
Volume:
133.31K
Avg Vol (2M):
243.43K
Trade In:
Volume:
133.31K
At Loss
Avg Vol (2M):
243.43K

Business Description

Description
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 869.47
Equity-to-Asset 0.98
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.07
9-Day RSI 46.76
14-Day RSI 53.5
6-1 Month Momentum % 62.41
12-1 Month Momentum % 55.91

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 46.87
Quick Ratio 46.87
Cash Ratio 45.52

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -23.72

Financials (Next Earnings Date:2024-11-29 Est.)

TRML's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TRML

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tourmaline Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.47
Beta 0
Volatility % 0
14-Day RSI 53.5
14-Day ATR ($) 1.538327
20-Day SMA ($) 27.21675
12-1 Month Momentum % 55.91
52-Week Range ($) 12.12 - 48.31
Shares Outstanding (Mil) 25.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tourmaline Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Tourmaline Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Tourmaline Bio Inc Frequently Asked Questions

What is Tourmaline Bio Inc(TRML)'s stock price today?
The current price of TRML is $25.52. The 52 week high of TRML is $48.31 and 52 week low is $12.12.
When is next earnings date of Tourmaline Bio Inc(TRML)?
The next earnings date of Tourmaline Bio Inc(TRML) is 2024-11-29 Est..
Does Tourmaline Bio Inc(TRML) pay dividends? If so, how much?
Tourmaline Bio Inc(TRML) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1